Ranibizumab and bevacizumab have similar efficacy. Reduction in the frequency of retreatment resulted in a small loss of efficacy irrespective of drug.
22q11.2DS (DiGeorge syndrome, or DGS) has a wide range of clinical features, including the following: Abnormal facies Congenital heart defects Hypoparathyroidism with hypocalcemia Cognitive, behavioral, and psychiatric problems Increased…